Inter and intra-country discrepancies have been observed in the distribution of MAF of the six NAT2 among a few AT-DILI and non-DILI TB populations, warranting a region/population-specific large sample size approach for interrogating NAT2 SNP as potential biomarkers for AT-DILI. The gene discussed is NAT2; the disease is tuberculosis.